EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Case Report: A Presentation of Early-Onset Immune-Mediated Bullous Pemphigoid in a Patient with Urothelial Cancer

Josep Sabaté Ortega iD, Roser Fort Culillas, Marina Escoda Garcia, Carmen Amalia Vásquez-Dongo, Núria Sala González

Current Oncology · 2023

DOI: 10.3390/curroncol30090566 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Current Oncology, 2023. Verfasst von Josep Sabaté Ortega und 4 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Department, Catalan Institute of Oncology, Hospital Universitari Doctor Josep Trueta, 17007 Girona, Spain. Hauptthemen laut MEDLINE: Pemphigoid, Bullous, Carcinoma, Transitional Cell, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cutaneous immune-related adverse events (cirAEs) are the most common side effects of immune checkpoint inhibitor (ICI) therapy (30–50% for all grades). The vast majority of them are low or mild and can be treated without ICI interruption. Autoimmune blistering disorders, such as immune-mediated bullous pemphigoid (IBP), are rare (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pemphigoid, BullousCarcinoma, Transitional CellUrinary Bladder NeoplasmsHumansImmune Checkpoint InhibitorsImmunotherapy

Stichwörter der Autor:innen

atezolizumabbullous pemphigoidimmune checkpoint inhibitorsimmune-related adverse events

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Oncology Department, Catalan Institute of Oncology, Hospital Universitari Doctor Josep Trueta, 17007 Girona, Spain.
  • Dermatology Department, Hospital Universitari Doctor Josep Trueta, 17007 Girona, Spain.
  • Pathology Department, Hospital Universitari Doctor Josep Trueta, 17007 Girona, Spain.

ORCID-Profile: Josep Sabaté Ortega

Zitieren

APA

Sabaté Ortega, J., Fort Culillas, R., Escoda Garcia, M., Vásquez-Dongo, C. A., & Sala González, N. (2023). Case Report: A Presentation of Early-Onset Immune-Mediated Bullous Pemphigoid in a Patient with Urothelial Cancer. Current Oncology. https://doi.org/10.3390/curroncol30090566

Vancouver

Sabaté Ortega J, Fort Culillas R, Escoda Garcia M, Vásquez-Dongo CA, Sala González N. Case Report: A Presentation of Early-Onset Immune-Mediated Bullous Pemphigoid in a Patient with Urothelial Cancer. Current Oncology. 2023. doi:10.3390/curroncol30090566

BibTeX
@article{SabatOrtega2023,
  author = {Sabaté Ortega, Josep and Fort Culillas, Roser and Escoda Garcia, Marina and Vásquez-Dongo, Carmen Amalia and Sala González, Núria},
  title = {Case Report: A Presentation of Early-Onset Immune-Mediated Bullous Pemphigoid in a Patient with Urothelial Cancer},
  journal = {Current Oncology},
  year = {2023},
  doi = {10.3390/curroncol30090566}
}
Kostenlos starten →